Moderna Wins Initial $20M Grant from Gates Foundation
Grant to fund preclinical study, Phase I trial of mRNA-based antibody combination therapeutics toward preventing HIV, with potential to grow into a $100M commitment
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
